KR102202236B1 - Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it - Google Patents

Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it Download PDF

Info

Publication number
KR102202236B1
KR102202236B1 KR1020190038958A KR20190038958A KR102202236B1 KR 102202236 B1 KR102202236 B1 KR 102202236B1 KR 1020190038958 A KR1020190038958 A KR 1020190038958A KR 20190038958 A KR20190038958 A KR 20190038958A KR 102202236 B1 KR102202236 B1 KR 102202236B1
Authority
KR
South Korea
Prior art keywords
kojic acid
adipocyte differentiation
sulfide derivative
cosmetic composition
acid sulfide
Prior art date
Application number
KR1020190038958A
Other languages
Korean (ko)
Other versions
KR20200117189A (en
Inventor
이재성
Original Assignee
주식회사 삼팔코스메틱
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 삼팔코스메틱 filed Critical 주식회사 삼팔코스메틱
Priority to KR1020190038958A priority Critical patent/KR102202236B1/en
Publication of KR20200117189A publication Critical patent/KR20200117189A/en
Application granted granted Critical
Publication of KR102202236B1 publication Critical patent/KR102202236B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)

Abstract

본 발명은 하기 화학식 1로 표시되는 코지산 설파이드 유도체 화합물을 유효성분으로 함유하는 지방세포 분화 촉진용 화장료 조성물에 관한 것이다
[화학식 1]

Figure 112019034238408-pat00005

R은 사이클로 헥실 또는 아다만틸이다.The present invention relates to a cosmetic composition for promoting adipocyte differentiation comprising a kojic acid sulfide derivative compound represented by the following formula (1) as an active ingredient.
[Formula 1]
Figure 112019034238408-pat00005

R is cyclohexyl or adamantyl.

Description

지방세포 분화 촉진 효능을 갖는 코지산 설파이드 유도체 화합물 및 이를 함유하는 화장료 조성물 {Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it}Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it}

본 발명은 지방세포 분화 촉진 효능을 갖는 코지산 설파이드 유도체 화합물 및 이를 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a kojic acid sulfide derivative compound having an adipocyte differentiation promoting effect and a cosmetic composition containing the same.

피부는 표피, 진피, 그리고 피하지방으로 구성되는 데 피부의 기본적인 구조는 피하지방조직에 의해 유지된다, 이러한 피하지방 조직은 피부의 볼륨과 강도를 좌우하는 중요한 역할을 한다. 따라서 위에서 언급한 바와 같이 기존에 사용되고 있던 피부 외곽층에 있는 진피나 표피에 탄력을 부여하는 방법보다 지방조직의 부피를 증가시키는 것이 피부의 볼륨 및 탄력을 유지할 수 있는 좋은 해결책이 될 수 있다. 지방세포를 이용한 연구는 다양한 분야에서 활발하게 진행되고 있다. 일반적으로 사용되는 지방전구세포 (preadipocyte)는 인슐린과 같은 분화 유도 물질에 의해 지방세포로 분화되는 특성을 가지고 있기 때문에 널리 사용되는 세포이다. 이러한 지방세포를 이용한 연구에 있어서 최근 주목을 받고 있는 것이 중간엽줄기세포 (mesenchymal stem cell)이다. 지방유래 중간엽줄기세포는 지방전구세포를 지방세포로 분화시키는데 사용되는 방법과 유사한 방법을 이용하여 분화시킬 수 있기 때문에 (Exp. Cell Res. 2006, 312, 1856), 지방세포 분화 연구에 널리 이용되고 있다 (Science 1999, 284, 143). 이러한 지방유래 중간엽줄기세포는 지방세포 뿐만 아니라 연골세포, 뼈세포 등의 다른 유형의 세포로도 분화될 수 있다고 알려져 있으며 (J. Cell Sci. 2006 119, 2204), 신체 대부분의 조직에 분포되어 있다. The skin is composed of the epidermis, the dermis, and the subcutaneous fat, and the basic structure of the skin is maintained by the subcutaneous fat tissue. This subcutaneous fat tissue plays an important role in determining the volume and strength of the skin. Therefore, as mentioned above, increasing the volume of adipose tissue can be a good solution to maintain the volume and elasticity of the skin than the method of imparting elasticity to the dermis or epidermis in the outer layer of the skin that has been used previously. Research using adipocytes is being actively conducted in various fields. Adipocytes commonly used are cells that are widely used because they have the property of differentiating into adipocytes by differentiation-inducing substances such as insulin. Mesenchymal stem cells have recently attracted attention in research using adipocytes. Adipose-derived mesenchymal stem cells can be differentiated using a method similar to that used to differentiate adipocytes into adipocytes (Exp. Cell Res. 2006, 312, 1856), so they are widely used in adipocyte differentiation studies. (Science 1999, 284, 143). It is known that these adipose-derived mesenchymal stem cells can differentiate into not only adipocytes but also other types of cells such as chondrocytes and bone cells (J. Cell Sci. 2006 119, 2204), and are distributed in most tissues of the body. have.

노화가 진행됨에 따라 피부에서는 주름이 생성되고, 동시에 탄력도 감소한다. 주름 생성과 탄력 감소와 같은 피부 노화는 피부 구성 요소인 콜라겐 (collagen), 엘라스틴 (elastin) 과 같은 피부 섬유의 분해 및 감소와 함께 지방세포의 활성 감소, 또 이에 의한 지방구 (lipid droplet) 감소에 의해서 일어나는 복합 현상이다. 그러므로 사람의 지방 세포 분화를 촉진하여 지방구를 생성 및 축적할 수 있다면, 피부의 주름 개선 및 탄력을 개선할 수 있다.As aging progresses, wrinkles are formed in the skin and elasticity decreases at the same time. Skin aging, such as wrinkle formation and elasticity reduction, decomposes and decreases skin fibers such as collagen and elastin, which are components of the skin, and decreases the activity of adipocytes, and thereby decreases lipid droplets. It is a complex phenomenon caused by. Therefore, if it is possible to produce and accumulate fat cells by promoting the differentiation of human fat cells, it is possible to improve the wrinkles and elasticity of the skin.

선행 연구 결과에 의하면 코지산에 신남산이 에스테르 결합으로 연결된 유도체 들이 신남산보다 지방세포 분화 촉진 효과가 크게 증가됨이 보고 되었다 (Bioorg. Med. Chem. Lett. 2014, 24, 2141, Bioorg. Med. Chem. 2018, 26, 5654, 특허 번호 10-2016-0086681). 지방세포 분화 촉진 효과에서 코지산이 가지고 있는 히드록시 피라논 모핵이 파마코 포어 (Pharmacophore) 역할을 함을 알 수 있다. 상기 문헌에 개시된 화합물들은 우수한 지방세포 분화 효과를 나타내지만 신남산과 코지산이 에스테르 결합으로 연결된 화합물로서 염기 조건하에서 쉽게 가수분해되는 단점을 가지고 있다. 이에 본 발명자들은 지방 세포 분화 촉진 효과를 나타내면서, 구조적으로 안정한 코지산 유도체들에 대한 연구를 진행하는 중 사이클 헥산과 아다만탄 (adamantane) 모핵을 함유하는 설파이드 코지산 유도체들의 경우 지방 세포 분화 촉진 효과가 있음을 확인하고 본 발명을 완성하였다. 설파이드 구조는 염기 조건하에서도 안정한 구조이다. 코지산 설파이드 유도체 화합물의 미백효과에 대한 효능은 선행 특허문헌에서 공지되어 있다 (특허 번호 10-1216949). 하지만 지방세포 분화 촉진 효과에 대해서는 알려진 바가 없다. According to the results of previous studies, it was reported that derivatives of cinnamic acid linked to kojic acid through ester bonds have a significantly increased adipocyte differentiation promoting effect than cinnamic acid (Bioorg. Med. Chem. Lett. 2014, 24, 2141, Bioorg. Med. Chem. 2018, 26, 5654, Patent No. 10-2016-0086681). In the adipocyte differentiation promoting effect, it can be seen that the hydroxypyranone hair nucleus of kojic acid plays a role of Pharmacopore. The compounds disclosed in the above document exhibit excellent adipocyte differentiation effect, but as compounds in which cinnamic acid and kojic acid are linked by an ester bond, they are easily hydrolyzed under basic conditions. Accordingly, the inventors of the present invention have shown the effect of promoting adipocyte differentiation and promoting adipocyte differentiation in the case of sulfide kojic acid derivatives containing cyclic hexane and adamantane mother nuclei while conducting research on structurally stable kojic acid derivatives. It was confirmed that the present invention was completed. The sulfide structure is a structure that is stable even under basic conditions. The efficacy of the kojic acid sulfide derivative compound on the whitening effect is known in the prior patent literature (Patent No. 10-1216949). However, the effect of promoting adipocyte differentiation is unknown.

[문헌 1] 대한민국 등록특허공보 제10-1216949호(2012.12.24. 등록)[Document 1] Korean Patent Publication No. 10-1216949 (registered on December 24, 2012)

본 발명의 목적은 하기 화학식 1로 표시되는 코지산 설파이드 유도체 화합물 및 이를 함유하는 화장료 조성물을 제공하는 것이다.An object of the present invention is to provide a kojic acid sulfide derivative compound represented by the following formula (1) and a cosmetic composition containing the same.

[화학식 1][Formula 1]

Figure 112019034238408-pat00001
Figure 112019034238408-pat00001

R은 사이클로 헥실 또는 아다만틸이다.R is cyclohexyl or adamantyl.

본 발명의 해결하고자 하는 과제는 언급한 과제로 제한되지 않는다. 언급하지 않은 다른 기술적 과제들은 이하의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.The problem to be solved of the present invention is not limited to the mentioned problem. Other technical problems that are not mentioned will be clearly understood by those of ordinary skill in the art from the following description.

상기와 같은 과제를 해결하기 위하여 본 발명의 실시예에 의한 지방세포 분화 촉진 효능을 갖는 코지산 설파이드 유도체 화합물은, 하기 화학식 1로 표시되는 코지산 설파이드 유도체 화합물인 것을 특징으로 한다.In order to solve the above problems, the kojic acid sulfide derivative compound having an adipocyte differentiation promoting effect according to an embodiment of the present invention is a kojic acid sulfide derivative compound represented by the following formula (1).

[화학식 1][Formula 1]

Figure 112019034238408-pat00002
Figure 112019034238408-pat00002

R은 사이클로 헥실 또는 아다만틸이다.R is cyclohexyl or adamantyl.

본 발명은 지방세포 분화 촉진 효과를 나타내는 코지산 설파이드 유도체 화합물에 관한 것으로서, 실험결과 인간의 지방유래 중간엽줄기세포의 아디포넥틴 발현양을 증가시키고, 또 이를 영양화장수와 영양크림의 조성물로 사용한 결과 피부의 주름 개선 및 탄력이 개선되는 효과를 얻었다.The present invention relates to a sulfide derivative compound of kojic acid that exhibits an adipocyte differentiation promoting effect. As a result of the experiment, the amount of adiponectin expression in human adipose-derived mesenchymal stem cells was increased, and as a result of using it as a composition of nutrient cosmetic water and nutrition cream, skin The effect of improving wrinkles and improving elasticity was obtained.

이하, 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.

상기 방법에 따른 제조 방법을 하기 반응식 (1)을 예로 들어 설명한다. 염화 코지산과 사이클로 헥산 티올 금속염 또는 아다만탄 티올 금속염을 반응시켜 설파이드 화합물 제조하는 단계 :The manufacturing method according to the above method will be described by taking the following reaction formula (1) as an example. Preparing a sulfide compound by reacting a chlorinated kojic acid with a cyclohexane thiol metal salt or an adamantane thiol metal salt:

를 포함하는 것을 특징으로 한다.It characterized in that it comprises a.

[반응식 1] [Scheme 1]

Figure 112019034238408-pat00003
Figure 112019034238408-pat00003

본 발명에 따른 코지산 설파이드 유도체 화합물의 제조방법은 상기한 반응식 1 에서 알 수 있는 바와 같이, 구체적으로 설명하면 다음과 같다. 본 단계에서 금속으로는 나트륨, 칼륨, 세슘 등이 사용될 수 있으며, 유기용매로는 디클로메탄, 클로로포름, 테트라하이드로퓨란, 디메틸포름아미드, 디메틸설폭사이드 등이 사용 가능하다. 또한 반응온도는 10 - 80oC가 가능하나 30oC 온도가 바람직하다.The method for preparing the kojic acid sulfide derivative compound according to the present invention is described in detail as follows, as can be seen in the above-described Scheme 1. In this step, sodium, potassium, cesium, etc. may be used as the metal, and dichloromethane, chloroform, tetrahydrofuran, dimethylformamide, dimethyl sulfoxide, and the like may be used as the organic solvent. In addition, the reaction temperature can be 10-80 o C, but 30 o C is preferred.

상기의 제조방법에 의해 얻어지는 화학식 1의 코지산 설파이드 유도체 화합물의 구체적인 예로는,Specific examples of the kojic acid sulfide derivative compound of Formula 1 obtained by the above production method,

2-(사이클로헥실티오메틸)-5-히드록시-4H-피란-4-온,2-(cyclohexylthiomethyl)-5-hydroxy-4H-pyran-4-one,

2-(아다만틸티오메틸)-5-히드록시-4H-피란-4-온,2-(adamantylthiomethyl)-5-hydroxy-4H-pyran-4-one,

을 들 수 있다.Can be mentioned.

상기한 제조방법에 의해 제조한 화학식 1로 표시되는 코지산 설파이드 유도체 화합물은 지방세포 분화를 촉진함으로써 지방구를 생성 및 축적할 수 있으므로 피부의 주름 개선 및 탄력을 개선할 수 있다.The kojic acid sulfide derivative compound represented by Formula 1 prepared by the above manufacturing method promotes the differentiation of adipocytes to generate and accumulate adipocytes, thereby improving wrinkles and elasticity of the skin.

이하, 실시예 및 시험예를 통하여 본 발명에 따른 코지산 설파이드 유도체 화합물의 제조방법 및 지방세포 분화 효과를 보다 구체적으로 설명한다.Hereinafter, the method for preparing the kojic acid sulfide derivative compound according to the present invention and the effect of adipocyte differentiation will be described in more detail through Examples and Test Examples.

[실시예 1] 2-(사이클로헥실티오메틸)-5-히드록시-4H-피란-4-온의 제조[Example 1] Preparation of 2-(cyclohexylthiomethyl)-5-hydroxy-4H-pyran-4-one

디메틸포름아미드 100mL에 클로로코지산 (5.0g)과 사이클로 헥산 티올 나트륨염 (4.3g)을 넣고 반응온도를 30도에서 3시간 동안 교반하였다. 반응이 완결된 것을 TLC로 확인하고 디메틸포름아미드를 농축하여 고체화합물을 얻었다. 이를 다시 초산에틸 200mL에 녹여 5% HCl 수용액 (100mL) 으로 2회 세척하고, 황산마그네슘으로 건조시켜 절반으로 농축하여 석출되는 결정을 여과하여 순수한 목적물 5.6g (수율 75%)을 얻었다.To 100 mL of dimethylformamide, chlorokojic acid (5.0 g) and cyclohexane thiol sodium salt (4.3 g) were added, and the reaction temperature was stirred at 30° C. for 3 hours. The completion of the reaction was confirmed by TLC, and dimethylformamide was concentrated to obtain a solid compound. This was again dissolved in 200 mL of ethyl acetate, washed twice with 5% HCl aqueous solution (100 mL), dried over magnesium sulfate, concentrated in half, and the precipitated crystals were filtered to obtain 5.6 g (yield 75%) of the pure target product.

1H NMR (300MHz, DMSO-d6) : 9.12 (s, 1H), 8.04 (s, 1H), 6.39 (s, 1H), 3.67 (s, 2H), 2.69 (m, 1H), 1.90 (m, 2H), 1.65 (m, 2H), 1.51 - 0.90 (m, 6H). 1 H NMR (300MHz, DMSO-d 6 ): 9.12 (s, 1H), 8.04 (s, 1H), 6.39 (s, 1H), 3.67 (s, 2H), 2.69 (m, 1H), 1.90 (m , 2H), 1.65 (m, 2H), 1.51-0.90 (m, 6H).

[실시예 2] 2-(아다만틸티오메틸)-5-히드록시-4H-피란-4-온의 제조[Example 2] Preparation of 2-(adamantylthiomethyl)-5-hydroxy-4H-pyran-4-one

헥산 티올 나트륨염 대신에 아다만탄 티올 나트륨염을 사용하는 것을 제외하고, 실시예 1과 동일한 방법을 사용하여 목적 화합물 (7.3g, 77%)을 수득하였다.The target compound (7.3g, 77%) was obtained in the same manner as in Example 1, except that adamantane thiol sodium salt was used instead of hexane thiol sodium salt.

1H NMR (300MHz, DMSO-d6) : 9.09 (s, 1H), 8.03 (s, 1H), 6.44 (s, 1H), 3.67 (s, 2H), 1.99 (s, 3H), 1.80 (s, 6H), 1.63 (s, 6H). 1 H NMR (300MHz, DMSO-d 6 ): 9.09 (s, 1H), 8.03 (s, 1H), 6.44 (s, 1H), 3.67 (s, 2H), 1.99 (s, 3H), 1.80 (s , 6H), 1.63 (s, 6H).

[시험예 1] 인간의 지방유래 중간엽줄기세포의 아디포넥틴 발현량 측정 [Test Example 1] Measurement of adiponectin expression level in human adipose-derived mesenchymal stem cells

아디포넥틴은 지방세포에서 분비되는 대표적인 단백질 호르몬이다. 이러한 아디포넥틴은 지방세포가 분화함에 따라 그 발현이 증가되는 것으로 보고되어 있다. 따라서 지방세포 분화 촉진의 지표인 아디포넥틴이 세포 배양 배지로 분비되는 양을 측정하였다. 아디포넥틴의 분비량을 측정하기 위해 지방 분화 14일 째에 세포 배양 배지를 채취한 후, 아디포넥틴 ELISA Kit(R&D systems, cat. No. DY1065)를 이용하여 아디포넥틴의 양을 정량하였다 (각 데이터 값은 대조군으로 보정하였다.). 아디포넥틴 ELISA Kit를 이용한 구체적인 측정 방법은 다음과 같다. Capture antibody를 96well plate에 반응시키고, washing buffer 로 씻은 후 sample을 가해 상온에서 2시간 동안 반응시킨다. 그 후 각 단계를 넘어갈 때 마다 3번씩 washing을 하면서, detection antibody, HRP enzyme, substrate solution, stop solution을 차례로 가하고 protocol에 제시된 시간만큼 반응시킨다. 최종 반응 후 Spectrophotometer 를 이용하여 450nm의 파장에서 흡광도를 측정한다. 결과를 표 1에 나타내었다.Adiponectin is a representative protein hormone secreted by adipocytes. It has been reported that the expression of adiponectin increases as adipocytes differentiate. Therefore, the amount of adiponectin, an indicator of adipocyte differentiation promotion, secreted into the cell culture medium was measured. To measure the secretion of adiponectin, the cell culture medium was collected on the 14th day of adipogenic differentiation, and then the amount of adiponectin was quantified using the adiponectin ELISA Kit (R&D systems, cat. No. DY1065) (each data value was used as a control group). Corrected.). The specific measurement method using the adiponectin ELISA Kit is as follows. The capture antibody was reacted to a 96-well plate, washed with a washing buffer, added to the sample, and reacted at room temperature for 2 hours. After that, each time each step is passed, the detection antibody, HRP enzyme, substrate solution, and stop solution are sequentially added while washing three times and reacted for the time indicated in the protocol. After the final reaction, the absorbance is measured at a wavelength of 450 nm using a spectrophotometer. The results are shown in Table 1.

[아디포넥틴 발현양 결과][Result of adiponectin expression level] 물질matter 아디포넥틴 (pg/ml, Avg ± S.D.)Adiponectin (pg/ml, Avg ± S.D.) 비처리군Untreated group 45 ± 1045 ± 10 IDX 처리군IDX treatment group 401 ± 30401 ± 30 IDX + glibenclamideIDX + glibenclamide 1850 ± 901850 ± 90 IDX + kojic acid (500μM)IDX + kojic acid (500μM) 403 ± 95403 ± 95 IDX + 실시예 1 (100μM)IDX + Example 1 (100 μM) 1704 ± 100 1704 ± 100 IDX + 실시예 2 (100μM)IDX + Example 2 (100 μM) 1620 ± 110 1620 ± 110

아디포넥틴 발현양 증가 실험에서 코지산은 효과를 나타내지 않았다. 하지만 실시예 1과 실시예2 코지산 설파이드 유도체 화합물은 아디포넥팀 발현양을 증가 시켰다.In the experiment to increase the adiponectin expression level, kojic acid did not show any effect. However, Examples 1 and 2 of the kojic acid sulfide derivative compounds increased the expression level of adiponectim.

[제형예 1] 영양화장수(밀크로션)의 제조[Formulation Example 1] Preparation of nutrient cosmetic water (milk lotion)

상기 실시예 1-2에서 제조한 코지산 설파이드 유도체 화합물을 함유하는 영양화장수를 제조하였다.A nutrient lotion containing the kojic acid sulfide derivative compound prepared in Example 1-2 was prepared.

성분ingredient 함량(중량 %)Content (% by weight) 1. 정제수1. Purified water 잔량Balance 2. 글리세린2. Glycerin 8.08.0 3. 부틸렌글라이콜3. Butylene glycol 4.04.0 4. 히아로론산 추출물4. Hyaluronic acid extract 5.05.0 5. 베타글루칸5. Beta Glucan 7.07.0 6. 카보머6. Carbomer 0.10.1 7. 실시예 1-27. Example 1-2 적량Appropriate amount 8. 카프릴릭/카프릭 트리글리세라이드8. Caprylic/Capric Triglyceride 8.08.0 9. 스쿠알렌9. Squalene 5.05.0 10. 세테아릴 글루코사이드10. Cetearyl Glucoside 1.51.5 11. 소르비탄 스테아레이트11.Sorbitan stearate 0.40.4 12. 세테아릴 알코올12. Cetearyl Alcohol 1.01.0 13. 방부제13. Preservative 적량Appropriate amount 14. 향14. Incense 적량Appropriate amount 15. 색소15. Pigment 적량Appropriate amount 16. 트리에탄올아민16. Triethanolamine 0.10.1

[제형예 2] 영양크림의 제조[Formulation Example 2] Preparation of nourishing cream

상기 실시예 1-3에서 제조한 코지산 설파이드 유도체 화합물을 함유하는 영양크림을 제조하였다.A nutritional cream containing the kojic acid sulfide derivative compound prepared in Example 1-3 was prepared.

성분ingredient 함량(중량 %)Content (% by weight) 1. 정제수1. Purified water 잔량Balance 2. 글리세린2. Glycerin 3.03.0 3. 부틸렌글라이콜3. Butylene glycol 3.03.0 4. 유동파라핀4. Liquid paraffin 7.07.0 5. 베타글루칸5. Beta Glucan 7.07.0 6. 카보머6. Carbomer 0.10.1 7. 실시예 1-27. Example 1-2 적량Appropriate amount 8. 카프릴릭/카프릭 트리글리세라이드8. Caprylic/Capric Triglyceride 3.03.0 9. 스쿠알렌9. Squalene 5.05.0 10. 세테아릴 글루코사이드10. Cetearyl Glucoside 1.51.5 11. 소르비탄 스테아레이트11.Sorbitan stearate 0.40.4 12. 폴리솔베이트12. Polysorbate 1.21.2 13. 방부제13. Preservative 적량Appropriate amount 14. 향14. Incense 적량Appropriate amount 15. 색소15. Pigment 적량Appropriate amount 16. 트리에탄올아민16. Triethanolamine 0.10.1

Claims (2)

지방세포 분화 촉진 효능을 갖는 하기 화학식 1로 표시되는 코지산 설파이드 유도체 화합물을 이용하는 지방세포 분화 촉진 화장료 조성물.

[화학식 1]
Figure 112020063108576-pat00004

R은 사이클로 헥실 또는 아다만틸이다.
Adipocyte differentiation promoting cosmetic composition using a kojic acid sulfide derivative compound represented by the following formula (1) having an adipocyte differentiation promoting effect.

[Formula 1]
Figure 112020063108576-pat00004

R is cyclohexyl or adamantyl.
삭제delete
KR1020190038958A 2019-04-03 2019-04-03 Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it KR102202236B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190038958A KR102202236B1 (en) 2019-04-03 2019-04-03 Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190038958A KR102202236B1 (en) 2019-04-03 2019-04-03 Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it

Publications (2)

Publication Number Publication Date
KR20200117189A KR20200117189A (en) 2020-10-14
KR102202236B1 true KR102202236B1 (en) 2021-01-13

Family

ID=72846925

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190038958A KR102202236B1 (en) 2019-04-03 2019-04-03 Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it

Country Status (1)

Country Link
KR (1) KR102202236B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101216949B1 (en) * 2010-10-15 2013-01-02 주식회사 내추럴디자인 Kojic acid derivative having depigmenting activity, preparation method thereof and cosmetic composition containing the same

Also Published As

Publication number Publication date
KR20200117189A (en) 2020-10-14

Similar Documents

Publication Publication Date Title
EP2554178B1 (en) Expression modulator for clock gene period
EP2554177B1 (en) Cosmetic use of Elemi oil for improving rough skin resulting from the malfunction of the circadian rhythm
JP4939766B2 (en) Basement membrane stabilizer
KR101806115B1 (en) Enriched media of human adipose tissue-derived stem cells having skin regeneration or antiwrinkle effect and uses thereof
KR101453610B1 (en) Compositions for improving skin wrinkle or enhancing skin elasticity comprising geniposide as an active ingredient
KR102202236B1 (en) Kojic acid sulfide derivative having activity in the promotion of adipocyte differentiation and cosmetic composition containing it
JP6535505B2 (en) An agent for maintaining undifferentiated state of stem cells and an agent for promoting proliferation using the extract of Mannengtake mushroom
KR101244138B1 (en) Composition for promoting the production of epidermal growth factor
EP3385260B1 (en) Novel hydroxyl pyranone compound, method for producing same, and cosmetics composition comprising compound
CN105188711B (en) Dermatologic preparation composition containing ginsenoside RH4
WO2014171279A1 (en) 1,5-anhydro-d-glucitol-containing collagen production accelerator
KR101991599B1 (en) Agent for maintaining stem cells in undifferentiated state and agent for promoting growth thereof
JP6272814B2 (en) Hyaluronic acid production promoter
JP2012121856A (en) Vegf production promoter, igf-1 production promoter, hgf production promoter, and bmp-2 production promoter
KR101216949B1 (en) Kojic acid derivative having depigmenting activity, preparation method thereof and cosmetic composition containing the same
JP5312063B2 (en) FGF-7 production promoter, VEGF production promoter, IGF-1 production promoter, HGF production promoter, BMP-2 production promoter, FGF-18 production promoter, and type 2 testosterone 5α-reductase production inhibitor
EP3385259B1 (en) Novel hydroxyl pyranone compound, method for producing same, and cosmetics composition comprising compound
JP6587899B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
KR102430512B1 (en) Reelin/vegf-c production/activation promoter and skin external composition using the same
JP6744537B2 (en) Composition for promoting hair growth
JP6969760B2 (en) Composition that promotes hair growth
KR20190037754A (en) A composition containing trimethoxy phenyl compound for promoting adipocyte differentiation or adiponectin production
TWI568451B (en) Skin care products
JP7202610B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
JP2022022672A (en) Inflammatory cytokine inhibitor

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant